# Behavioral, antioxidant, and kynurenine pathway modulation of a specific strain of Ligilactobacillus salivarius in a preclinical model of depression

**Authors:** David Martín-Hernández, Javier R. Caso, César Díaz-García, Pedro-Antonio Regidor, José Miguel Rizo, Marta Román, Rocío Gutiérrez, Juan Carlos Leza

PMC · DOI: 10.1007/s00394-026-03941-9 · European Journal of Nutrition · 2026-03-09

## TL;DR

A specific strain of Ligilactobacillus salivarius may help reduce depression symptoms by improving antioxidant defenses and balancing harmful brain chemicals.

## Contribution

This study is the first to show that L. salivarius CECT 30632 modulates the kynurenine pathway and antioxidant systems in a rat model of depression.

## Key findings

- L. salivarius CECT 30632 reduced grooming latency in the splash test, suggesting improved anhedonia.
- The strain restored antioxidant markers like p-Nrf2 and GPx1 in stressed rats.
- It lowered the QUINA/KYNA ratio in plasma and frontal cortex, indicating reduced excitotoxic risk.

## Abstract

Current antidepressants targeting neurotransmitters often fail to alleviate symptoms. Alternative hypotheses suggest inflammation may trigger an alternative route that converts tryptophan into kynurenine, reducing the bioavailability of tryptophan to synthesize serotonin while producing neuroactive metabolites such as quinolinic acid (QUINA, excitotoxic) and kynurenic acid (KYNA, neuroprotective). This study evaluates the effects on these systems of a specific strain of Ligilactobacillus salivarius (L. salivarius), identified in the Spanish Type Culture Collection as CECT 30632, in a preclinical model depression.

Male Wistar rats (n = 32) were divided into control (CT) and chronic mild stress (CMS) groups, treated with either vehicle or L. salivarius CECT 30632 for four weeks, starting one week before CMS exposure. Behavioral assessments, including the splash test (ST) and open field test (OF), were conducted. Biochemical analyses of peripheral blood mononuclear cells (PBMCs), plasma, and frontal cortex (FC) samples assessed antioxidant markers phospho-nuclear factor (erythroid-derived 2)-like 2 (p-Nrf2) and glutathione peroxidase 1 (GPx1), as well as tryptophan metabolites.

In the ST, L. salivarius CECT 30,632 reduced latency to groom, indicating improved anhedonia and self-care, while no changes were observed in the OF test. CMS reduced p-Nrf2 and GPx1 expression in PBMCs, which was restored by L. salivarius CECT 30,632. This bacterium also reduced the QUINA/KYNA ratio in plasma and FC, suggesting a lower excitotoxicity risk.

Ligilactobacillus salivarius CECT 30632 improved behavioral outcomes, enhanced antioxidant defenses, and modulated tryptophan metabolism in a rat model of CMS. These findings support its potential as a probiotic intervention for depression.

The online version contains supplementary material available at 10.1007/s00394-026-03941-9.

## Linked entities

- **Genes:** GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], GPX1 (glutathione peroxidase 1) [NCBI Gene 2876]
- **Chemicals:** tryptophan (PubChem CID 1148), kynurenine (PubChem CID 846), quinolinic acid (PubChem CID 1066), kynurenic acid (PubChem CID 3845)
- **Diseases:** depression (MONDO:0002050)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Diseases:** Depressive disorders (MESH:D003866), inflammatory drugs (MESH:D000081015), food deprivation (MESH:D012892), glutamate excitotoxicity (MESH:C537425), bipolar disorder (MESH:D001714), colitis (MESH:D003092), CMS (MESH:D000079225), mental diseases (MESH:D008607), hypercortisolism (MESH:D003480), weight gain (MESH:D015430), stress-related disorders (MESH:D000068099), Suicidal ideation (MESH:D001072), neurotoxic (MESH:D020258), mental disorders (MESH:D001523), anxiety (MESH:D001007), CNS disorders (MESH:D002493), FC (MESH:D000303), inflammation (MESH:D007249), anhedonia (MESH:D059445)
- **Chemicals:** alcohol (MESH:D000438), Tryptophan (MESH:D014364), PBS (MESH:D007854), Tween 20 (MESH:D011136), desipramine (MESH:D003891), indole (MESH:C030374), 5-HT (MESH:D012701), fluoxetine (MESH:D005473), sucrose (MESH:D013395), LPS (MESH:D008070), CMS (-), kynurenine (MESH:D007737), sodium dodecyl sulfate (MESH:D012967), QUINA (MESH:D017378), ethanol (MESH:D000431), Vetoquinol (MESH:C121357), L-leucine (MESH:D007930), desvenlafaxine (MESH:D000069468), indoles (MESH:D007211), escitalopram (MESH:D000089983), duloxetine (MESH:D000068736), EDTA (MESH:D004492), lactic acid (MESH:D019344), KYNA (MESH:D007736), sodium pentobarbital (MESH:D010424), paroxetine (MESH:D017374), Corticosterone (MESH:D003345)
- **Species:** gut metagenome (species) [taxon 749906], Bos taurus (bovine, species) [taxon 9913], Ligilactobacillus salivarius (species) [taxon 1624], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Bifidobacterium (genus) [taxon 1678], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12971813/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12971813/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12971813/full.md

---
Source: https://tomesphere.com/paper/PMC12971813